coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Rochdale North PCN, Rochdale (LAD) · Health Inequalities Profile

    PCN U64487 · NHS Greater Manchester Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    61,233

    Registered population

    59.9% aged 18–64

    17.1%

    Aged 65+

    ICB 14.9% · England 17.9%

    49.4%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~26,274

    Core20 residents (est.)

    Resident basis; registered basis ~30,428 · see page 3

    9,691

    Hypertension register

    +6.95% in 3 yrs · England +5.60%

    742

    SMI register

    23.8% of Rochdale (LAD)'s

    1,299

    COPD register

    Reviews +8.52% in 3 yrs

    Forecast to 2030

    11,206

    Hypertension patients, 2030

    +1,515 on today

    77.5%

    QRISK ≥20% on statins, 2030

    +3.24pp over 3 yrs

    4.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    1,611
    Unreviewed asthma cohort despite rapid three-year gain.

    Annual asthma reviews rose +18.2% over 2023 to 2025 (England +4.4%) to 63.3% (England 65.7%), leaving about 1,600 patients unreviewed.

    6.5 pp
    Age-five MMR drops between first and second doses.

    In Q1 2025/26, age-five MMR coverage fell from 96.8% at dose 1 to 90.3% at dose 2, and by 16 pp at Ashworth Street.

    70.6%
    High-risk statin cover exceeds England, unit cost higher.

    Lipid-lowering therapy for QRISK ≥ 20% exceeds England (63.6%), though adult prescribing is 2,098 per 1,000 (England 4,100) and costs £23,764 more than England's.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A list of 61,233 balances above-average youth shares with 10,504 older patients

    Across 61,233 registered patients, 22.9% (14,047) are aged 0-17, compared to 23.5% in Rochdale (LAD), 21.8% in NHS Greater Manchester ICB, and 19.6% in England. Patients aged 65+ comprise 17.1% (10,504), above Rochdale (LAD) (14.7%) and the ICB (14.9%), but below England (17.9%). Practice youth shares range from 18.7% at Edenfield Road Surgery to 26.3% at Mark Street Surgery, with Ashworth Street Surgery at 23.3%. Gypsy or Irish Traveller and Roma groups each represent 0.1% of residents. Projected population growth to 2030 is 0.6% (methodology unverified). Registered list counts differ from resident Census bases.

    Age profile

    0–1722.9%
    18–6459.9%
    65+17.1%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Rochdale (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Rochdale LA)2,3002,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)78.2%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)55.2%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Rochdale LA)1,0881,0219552024/25
    Falls deaths, all ages, per 100,000 (Rochdale LA)19.018.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation affects 49.4% of patients, spanning a 91.4 pp spread across practices

    The PCN Core20 cohort is 49.4%, above Rochdale (LAD) at 48.0%, NHS Greater Manchester Integrated Care Board at 40.7%, and England at 21.0%. Across practices, Core20 concentration spans a 91.4 pp range. Healey Surgery is at 8.6%. Inspire Medical Centre is at 100.0%. By volume, Ashworth Street Surgery carries 8,198 estimated Core20 patients at 48.6%. Practice-level registered estimates sum to 30,428, whereas estimated resident Core20 population is 26,274. Targeting must balance intense practice concentration against absolute patient volume.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Inspire100.0% · 4,467 patients
    Mark Street75.6% · 7,705 patients
    Yorkshire St66.3% · 4,020 patients
    Dawes49.0% · 3,622 patients
    Ashworth Street48.6% · 8,198 patients
    Edenfield Road18.4% · 1,914 patients
    Healey8.6% · 502 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    742

    SMI register

    1.18% recorded prevalence

    393

    Learning disability register

    0.63% recorded prevalence

    33

    Care homes, 783 beds

    In the PCN catchment

    9.7%

    Provide unpaid care

    Rochdale (LAD), Census 2021

    The PCN records 742 patients on the severe mental illness register (1.2% prevalence, England 1.0%) and 393 on the learning disability register (0.6%, England 0.6%). Catchment services include 33 care homes with 783 beds, though bed capacity does not establish registered resident numbers. Severe mental illness prevalence exceeding England (1.0%) indicates sustained capacity is needed for annual physical health checks.

    Severe mental illness: physical health checks

    SMI prevalence is 1.2% (England 1.0%). Recorded checks reached 82.3% for blood pressure (England 83.4%) and 82.5% for BMI (England 82.1%), with alcohol status at 81.7%. Tracking missing check elements separately is necessary to secure full physical reviews.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    9,691

    Hypertension register

    +6.95%

    Register growth, 3 yrs

    Rochdale (LAD) +6.17% · England +5.60%

    +5.28pp

    BP control, under 80

    ≤140/90 · +3.91pp aged 80+

    +1,515

    More patients by 2030

    Forecast 11,206 (17.65%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 15.4% (9,691 patients), compared with 15.6% in Rochdale, 14.4% in the ICB, and 15.2% in England. Recent blood pressure recording reached 88.1%, trailing Rochdale (89.5%), the ICB (90.3%), and England (90.0%). For patients under 80, blood pressure control to <= 140/90 mmHg is 67.4% (England 67.8%, Rochdale 67.8%, ICB 68.6%), while overall treatment to target is 70.5% (England 70.3%). Observation periods and denominators were not captured. Trailing blood pressure recording and control rates may indicate recall gaps, which a clinical audit of uncontrolled patients could test.

    Lipids and statins

    Statin therapy reaches 70.6% for QRISK ≥ 20% (England 63.6%, Rochdale 68.3%) and 77.6% in CKD (England 70.3%), yet adult lipid-regulating prescribing is 2,098 items per 1,000 (England 4,100). Prescribing volume trailing England despite higher high-risk coverage could reflect differences in primary prevention initiation, which practice audits could verify.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202699,017£2.10£1.94£1.86£207,936
    Cardiovascular (all), 2025122,191£4.10£3.15£3.33£500,983

    In 2026, the PCN prescribed 99,017 lipid-regulating items at £2.10 per item, compared with £2.08 in Rochdale, £1.94 in the ICB, and £1.86 in England (£23,764 more than at England's unit cost). Higher unit cost than England may reflect formulary choices or dosing formulations, which a local prescribing audit could evaluate.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +18.18%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.68%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.5% (England 6.6%), with 5–19 asthma management prescribing at 1,941 per 1,000 (England 1,488). Annual asthma reviews rose +18.2% over 2023 to 2025 (England +4.4%) but stand at 63.3% (England 65.7%), leaving an estimated 1,611 patients without a recorded review. Second-hand smoke recording for ages 6–19 is 76.9% (Rochdale 81.6%), while COPD review coverage is 73.4% (England 76.4%). Below-comparator review rates alongside high youth prescribing suggest prioritising structured paediatric and adult respiratory reviews.

    Cancer register and children's immunisation

    In Q1 2025/26, 6-in-1 coverage at 12 months is 88.2% and MMR dose 1 at 24 months is 85.6%, both below the 95.0% target. At age 5, MMR dose 1 is 96.8%, but dose 2 is 90.3%—a 6.5 pp drop that reaches 16 pp at Ashworth Street Surgery. Cancer prevalence is 3.6% (England 3.8%). This dose drop-off could reflect second-dose recall gaps (unverified locally; a recall audit would test this).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months88.2%

    England 91.0%

    6-in-1 complete primary course at 24 months92.0%

    England 92.2%

    MMR dose 1 at 24 months85.6%

    England 88.3%

    MMR dose 2 at age 590.3%

    England 82.8%

    4-in-1 pre-school booster at age 589.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    Early-stage diagnosis (stages 1 and 2) in NHS Greater Manchester ICB was 55.6% in 2022 (6,491 of 11,679 known-stage cancers; England 55.3%), with distance to the 75.0% national ambition by 2028 of -19.4 pp, and 70.8% having a known stage (11,679 of 16,492 registered cancers). Reaching 75% requires 2,268.2 extra early cases a year (about 2,270). Primary care screening uptake in women aged 25-49 is 63.7% (Rochdale 68.8%, England 66.8%) and changed -1.4% over 2023 to 2025, while breast screening aged 53 to 70 is 67.6% (England 69.9%). Screening gaps may contribute to delayed detection, so targeted practice recall is warranted.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In provisional Jul 2026, Northern Care Alliance NHS Foundation Trust achieved 78.6% on the 62-day referral to treatment standard (distance to the 85.0% standard: -6.4 pp), ahead of Manchester University NHS Foundation Trust (72.8%), Tameside and Glossop Integrated Care NHS Foundation Trust (76.8%), NHS Greater Manchester Integrated Care Board (75.7%), and England (71.2%). On the 28-day faster diagnosis standard, Northern Care Alliance reached 75.2% (distance to the 75.0% standard: 0.2 pp), trailing Manchester University (80.1%), Tameside and Glossop (82.5%), the ICB (79.5%), and England (79.3%). Trust delays could lengthen diagnostic intervals for PCN referrals.

    Pathways within standard (%)Northern Care AllianceTameside and Glossop Integrated CareManchesterGreater Manchester ICBEngland
    28-day faster diagnosis (75%)75.2082.4880.0679.5379.32
    31-day treatment (96%)94.5496.2592.5496.4992.50
    62-day referral to treatment (85%)78.6576.7772.8575.7371.16
    Diagnostic waits over 6 weeks (%)Northern Care AllianceTameside and Glossop Integrated CareManchesterEngland
    MRI5.090.0011.6821.40
    CT4.100.1814.669.92
    Echocardiography31.480.004.9128.48
    Colonoscopy40.041.514.5130.83
    Gastroscopy36.485.4529.3529.02
    All 15 DM01 tests15.710.808.9823.14
    Community services activityRochdale residentsGreater Manchester ICB
    Care contacts60,250573,310
    Referrals9,45594,470
    Patients with a contact19,345183,535

    Community services (residents of Rochdale), Jun 2026 (provisional). In provisional Jun 2026 community services data for Rochdale borough residents (wider system data, not PCN level), 24,650 of 60,250 community contacts were with adults aged 65 and over, representing a 40.9% share. This older-adult share reflects borough-wide community activity, but individual PCN patient volumes are not captured in this dataset.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Inspire Medical Centre achieved 99.0% QOF clinical points alongside 100.0% Core20 share

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Ashworth Street13348.652.5%78.5%84.4%
    Yorkshire St9966.358.0%83.3%80.8%
    Dawes10749.045.6%76.2%76.2%
    Edenfield Road11518.449.7%71.3%76.1%
    Mark Street8375.638.0%83.7%75.7%
    Healey Surgery1018.656.2%72.3%73.4%
    Inspire75100.040.7%76.3%63.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNRochdale (LAD)AssetPCNRochdale (LAD)
    Care homes (catchment)33 (783 beds)n/aSchools (catchment)109n/a
    Children's centres817Places of worship60116
    Libraries312Primary schools (LA maintained)1438
    Primary academies1426Special schools12

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review recall

    Asthma review coverage is 63.3% (England 65.7%, Rochdale 66.2%) across 4,387 registered patients, leaving an estimated 1,611 (about 1,600) patients without a recorded review in 12 months. For discussion: the PCN could run structured recall using a single review template, prioritising high-prescribing youth cohorts and after-school slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Age-five MMR second-dose recall

    In Q1 2025/26, age-5 MMR coverage drops 6.5 pp from dose 1 (96.8%) to dose 2 (90.3%, below the 95.0% target by 4.7 pp) across 186 children, and 16 pp at Ashworth Street Surgery. For discussion: practices could audit age-five cohorts for missing second doses and offer catch-up slots. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Heart failure and CVD coding audit

    Heart failure prevalence is 1.0% (613 patients) against 1.1% in England and 1.2% in Rochdale, giving an unadjusted benchmark range of +59 to +104 patients across the 61,233 list. For discussion: practices could search records for cardiovascular medicines or discharge codes lacking a heart failure or stroke register entry. Low cost, quick to run.

    Evidence base: the stroke/TIA register is the cohort for AF anticoagulation and blood-pressure control (pre-stroke prevention) as well as hyperacute care; practices well below expected prevalence are the case-finding list, and the pre-stroke prevention gap concentrates in deprived practices.

    Policy anchor: Core20PLUS5 (CVD); NHS CVD ambitions to 2029.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Paediatric acute demand alignment (p2)Aged 0-17Medium Term Planning Framework 2026 · Neighbourhood health frameworkPCN
    Dual track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall and titration (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool MMR second dose recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured asthma review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Age-five MMR second-dose recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · Heart failure and CVD coding audit (p12)Registered population · Heart failure register · Heart Failure: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT · SSNAPPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15